Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration

Area of Science:

• Immunology
• Neuroscience
• Ophthalmology

Background:

• Retinal degeneration is a major cause of global vision loss, linked to neurodegenerative processes.
• Toll-like receptors (TLRs) are key in innate immunity and signal transduction.
• The complement system, particularly the alternative pathway, plays a role in retinal pathology.

Purpose of the Study:

• To investigate the role of Toll-like receptor 2 (TLR2) in oxidative stress-induced retinal degeneration.
• To determine if TLR2 mediates complement activation in the retina.
• To explore TLR2 as a therapeutic target for vision loss.

Main Methods:

• Studied the effects of TLR2 in retinal pigment epithelial (RPE) cells and mononuclear phagocytes.
• Utilized TLR2 neutralization and deficiency models in the context of oxidative stress.
• Assessed complement factor (C3, CFB) induction and alternative pathway activation.
• Evaluated photoreceptor neuron survival, RPE integrity, and immune cell infiltration (Iba1+).

Main Results:

• TLR2 induces complement factors C3 and CFB in RPE cells and phagocytes.
• Neutralizing TLR2 reduced C3 fragments and protected photoreceptors from oxidative damage.
• TLR2 deficiency preserved RPE tight junctions and prevented fragmentation.
• Terminal complement complex formation and Iba1+ cell infiltration were inhibited in TLR2-deficient retinas.

Conclusions:

• TLR2 acts as a critical mediator of retinal degeneration induced by oxidative stress.
• TLR2 bridges oxidative damage and complement-mediated retinal pathology.
• Targeting TLR2 offers a potential therapeutic strategy against vision loss from retinal degeneration.